Literature DB >> 34348456

FLT3-ITD signals bad news for core binding factor acute myeloid leukemia unless trisomy 22 comes to the rescue.

Sun Loo1, Andrew H Wei2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34348456      PMCID: PMC8968904          DOI: 10.3324/haematol.2021.279409

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

1.  Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.

Authors:  Guido Marcucci; Krzysztof Mrózek; Amy S Ruppert; Kati Maharry; Jonathan E Kolitz; Joseph O Moore; Robert J Mayer; Mark J Pettenati; Bayard L Powell; Colin G Edwards; Lisa J Sterling; James W Vardiman; Charles A Schiffer; Andrew J Carroll; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

2.  Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication.

Authors:  Nikolaus Jahn; Tobias Terzer; Eric Sträng; Anna Dolnik; Sibylle Cocciardi; Ekaterina Panina; Andrea Corbacioglu; Julia Herzig; Daniela Weber; Anika Schrade; Katharina Götze; Thomas Schröder; Michael Lübbert; Dominique Wellnitz; Elisabeth Koller; Richard F Schlenk; Verena I Gaidzik; Peter Paschka; Frank G Rücker; Michael Heuser; Felicitas Thol; Arnold Ganser; Axel Benner; Hartmut Döhner; Lars Bullinger; Konstanze Döhner
Journal:  Blood Adv       Date:  2020-12-22

Review 3.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Authors:  Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2016-11-28       Impact factor: 22.113

Review 4.  Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis.

Authors:  Kinkini N Magina; Gudrun Pregartner; Armin Zebisch; Albert Wölfler; Peter Neumeister; Hildegard T Greinix; Andrea Berghold; Heinz Sill
Journal:  Blood       Date:  2017-07-05       Impact factor: 22.113

5.  The genomic landscape of core-binding factor acute myeloid leukemias.

Authors:  Zachary J Faber; Xiang Chen; Amanda Larson Gedman; Kristy Boggs; Jinjun Cheng; Jing Ma; Ina Radtke; Jyh-Rong Chao; Michael P Walsh; Guangchun Song; Anna K Andersson; Jinjun Dang; Li Dong; Yu Liu; Robert Huether; Zhongling Cai; Heather Mulder; Gang Wu; Michael Edmonson; Michael Rusch; Chunxu Qu; Yongjin Li; Bhavin Vadodaria; Jianmin Wang; Erin Hedlund; Xueyuan Cao; Donald Yergeau; Joy Nakitandwe; Stanley B Pounds; Sheila Shurtleff; Robert S Fulton; Lucinda L Fulton; John Easton; Evan Parganas; Ching-Hon Pui; Jeffrey E Rubnitz; Li Ding; Elaine R Mardis; Richard K Wilson; Tanja A Gruber; Charles G Mullighan; Richard F Schlenk; Peter Paschka; Konstanze Döhner; Hartmut Döhner; Lars Bullinger; Jinghui Zhang; Jeffery M Klco; James R Downing
Journal:  Nat Genet       Date:  2016-10-31       Impact factor: 38.330

6.  Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

Authors:  Peter Paschka; Guido Marcucci; Amy S Ruppert; Krzysztof Mrózek; Hankui Chen; Rick A Kittles; Tamara Vukosavljevic; Danilo Perrotti; James W Vardiman; Andrew J Carroll; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

7.  Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.

Authors:  Christophe Willekens; Odile Blanchet; Aline Renneville; Pascale Cornillet-Lefebvre; Cécile Pautas; Romain Guieze; Norbert Ifrah; Hervé Dombret; Eric Jourdan; Claude Preudhomme; Nicolas Boissel
Journal:  Haematologica       Date:  2015-12-03       Impact factor: 9.941

8.  Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.

Authors:  Christoph Röllig; Hubert Serve; Andreas Hüttmann; Richard Noppeney; Carsten Müller-Tidow; Utz Krug; Claudia D Baldus; Christian H Brandts; Volker Kunzmann; Hermann Einsele; Alwin Krämer; Kerstin Schäfer-Eckart; Andreas Neubauer; Andreas Burchert; Aristoteles Giagounidis; Stefan W Krause; Andreas Mackensen; Walter Aulitzky; Regina Herbst; Mathias Hänel; Alexander Kiani; Norbert Frickhofen; Johannes Kullmer; Ulrich Kaiser; Hartmut Link; Thomas Geer; Albert Reichle; Christian Junghanß; Roland Repp; Frank Heits; Heinz Dürk; Jana Hase; Ina-Maria Klut; Thomas Illmer; Martin Bornhäuser; Markus Schaich; Stefani Parmentier; Martin Görner; Christian Thiede; Malte von Bonin; Johannes Schetelig; Michael Kramer; Wolfgang E Berdel; Gerhard Ehninger
Journal:  Lancet Oncol       Date:  2015-11-06       Impact factor: 41.316

9.  Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11.

Authors:  Yuichi Ishikawa; Naomi Kawashima; Yoshiko Atsuta; Isamu Sugiura; Masashi Sawa; Nobuaki Dobashi; Hisayuki Yokoyama; Noriko Doki; Akihiro Tomita; Toru Kiguchi; Shiro Koh; Heiwa Kanamori; Noriyoshi Iriyama; Akio Kohno; Yukiyoshi Moriuchi; Noboru Asada; Daiki Hirano; Kazuto Togitani; Toru Sakura; Maki Hagihara; Tatsuki Tomikawa; Yasuhisa Yokoyama; Norio Asou; Shigeki Ohtake; Itaru Matsumura; Yasushi Miyazaki; Tomoki Naoe; Hitoshi Kiyoi
Journal:  Blood Adv       Date:  2020-01-14

10.  The clinical mutatome of core binding factor leukemia.

Authors:  Sabrina Opatz; Stefanos A Bamopoulos; Klaus H Metzeler; Tobias Herold; Bianka Ksienzyk; Kathrin Bräundl; Sebastian Tschuri; Sebastian Vosberg; Nikola P Konstandin; Christine Wang; Luise Hartmann; Alexander Graf; Stefan Krebs; Helmut Blum; Stephanie Schneider; Christian Thiede; Jan Moritz Middeke; Friedrich Stölzel; Christoph Röllig; Johannes Schetelig; Gerhard Ehninger; Alwin Krämer; Jan Braess; Dennis Görlich; Maria Cristina Sauerland; Wolfgang E Berdel; Bernhard J Wörmann; Wolfgang Hiddemann; Karsten Spiekermann; Stefan K Bohlander; Philipp A Greif
Journal:  Leukemia       Date:  2020-01-02       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.